Fast track status may not have the cachet of some of the the US Food and Drug Administration's newer expedited review programs, but a surge in applications over the past five years shows its staying power.
The FDA received more than 2,200 requests for fast track status between fiscal year 1998 and 2019, agency data shows. After holding steady from 2004-2014 at around 80-100 requests a...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?